chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt dizzy, nauseas, and lightheaded like she might pass out. EMS came to take a look at her. Her blood pressure was elevated and her heart beat was rapid. This was not typical for her after vaccines. She felt this way around 5 minutes after receiving her second vaccine.
Vomiting; Strong headache; chills; Gas/ bloating; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 20Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was allergic to penicillin. There were no concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 27Feb2021 at 17:15 (at an unspecified age) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested positive for COVID-19. On 20Mar2021 at 17:30 the patient experienced vomiting, chills, strong headache, gas/ bloating and body aches. No treatment was received for the reported events. On an unspecified date, the patient had undergone COVID-19 saliva test and the result was negative. The clinical outcome of vomiting, chills, strong headache, gas/ bloating and body aches was resolved on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
Patient given vaccine, about 15 min later started to experience throat tingling/numbness and difficulty breathing. Vitals taken, Rapid Response called, takent to Emergency Room for evaluation. VS 97.7 F, 149/93, 78, 16
Was very tires right after. Starting at 11:00pm I had a nausea/dizzy. At 2:00am body aches started especially in joints and got a fever. fever was 102 for 24 hours.
Chest pain, heart palpitations, lightheaded, shortness of breath. No specific treatment plan. I was told to drink more water and work on my cholesterol and not lift heavily for weight lifting.
Body aches, headache, chills, fever, cough, fatigue  started 7 hours after vaccine  Rest, pushed fluids, Tylenol, prescription Singulair and Clarinex  45 hours after vaccine adverse reaction gone
My doctor's office gave me this second Shingrix shot in the upper left arm on Tuesday morning (3/29/22).  (The first Shingrix shot was given in the same arm a few months prior and I had absolutely no problems with the first shot.). The next morning on 3/30/22, I had a very red patch and soreness at the injection site.  In addition,  I felt like I was coming down with a stomach flu.  Specifically I was very nauseated, had diarrhea, and a sharp cramping pain on my lower right stomach.  On 3/31/22, I continued to feel sick with the same symptoms as the previous day but my lower right pain in my stomach was increasing.  I decided to the Emergency Room of Hospital.  They performed a CT Scan believing that I had appendicitis but it came back negative.  The doctor told me to take a few days off from work to get extra rest and drink plenty of fluids.  The following two days, I have slowly started to improve but have some continued pain in the lower right side of my abdomen. I have follow-up appointment with my doctor's office on Monday, 4/04/22.
temp; chills; freezing; aching; This is a spontaneous report from a contactable consumer (patient herself). A 76-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on 03Feb2021 as dose 2, single for COVID-19 immunisation. Historical vaccine included first dose via unspecified route on an unspecified date as dose 1, single for COVID-19 immunisation. Patients medical history and concomitant medications. Patient experienced temp, chills, freezing, aching the following day 04Feb2021. Patient reported feeling better at this time. The outcome of event was recovering.   Follow-up attempts are completed. No further information is expected.
101.7 degree fever for around 3 hours, the next day around 6pm.
Painful arm and knee next day, then radiated to ankle for about three days then disappeared.  Then patient reports feeling sick like flu, tired, for a week.  Then about a week later her arm started hurting again.  She called us at the pharmacy today.
it was rpt from health care professional concerning pt who was vax & exp cellulitis just beneath the axilla; pt sought unspecified medical attention
Lower back pain that suddenly went away; Soreness of the arm; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain that suddenly went away) and VACCINATION SITE PAIN (Soreness of the arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart rate irregular. Concurrent medical conditions included Asthma. Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Heart beat abnormal neonatal, LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced VACCINATION SITE PAIN (Soreness of the arm). On 30-Dec-2020, the patient experienced BACK PAIN (Lower back pain that suddenly went away). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 30-Dec-2020, VACCINATION SITE PAIN (Soreness of the arm) had resolved. On 11-Jan-2021, BACK PAIN (Lower back pain that suddenly went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included asthma inhaler.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up was received on 03 jun 2021 non significant case included back pain recovered.and no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Vaccine given to 1 year old- not an age appropriate administration - no adverse effects were reported
Started with chills, fever of 102.5, fatigue, headache, shaking, vomiting at 9:15 PM. Heart rate 95 and felt like heart was beating out of my chest. No chest pain or difficulty breathing. Took 1 Aleve at 11:30. At 12:30 am fever decreased to 101.5. General aches. Fever 101.5 at 4:00 am. Now at 11:15 am fever is 99.6. Feeling better but general fatigue and mild headache remains.
Patient presented 7/17/08 with golf ball size, red, raised, warm to touch area on left upper arm.  This was previous injection site of Varicella vaccine given on 7/15/08.  Doctor diagnosed with localized reaction to Varicella vaccine and treated with Benadryl TID x 1 week prn as well as warm compresses TID prn.  Follow up if symptoms persist.
This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Pain in knees and wrist feels like it is pulsating), INSOMNIA (Cant sleep because of pain), INFLAMMATION (inflammation), MUSCULOSKELETAL STIFFNESS (leg stiffening at night) and PAIN IN EXTREMITY (arms hands legs in pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced INFLAMMATION (inflammation), MUSCULOSKELETAL STIFFNESS (leg stiffening at night), PAIN IN EXTREMITY (arms hands legs in pain) and DYSSTASIA (difficult to get up). On 05-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and MYALGIA (Extremely muscle pain in legs and knees / muscle pains/excruciating muscle pain). On an unknown date, the patient experienced MUSCLE TWITCHING (Pain in knees and wrist feels like it is pulsating), INSOMNIA (Cant sleep because of pain), DIARRHOEA (diarrhea) and ARTHRALGIA (Pain in knees and wrist/extreme joint pain). The patient was treated with IBUPROFEN at a dose of 200 milligram; IBUPROFEN at a dose of 800 milligram; HYDROCODONE at an unspecified dose and frequency; HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE TWITCHING (Pain in knees and wrist feels like it is pulsating), INSOMNIA (Cant sleep because of pain) and DIARRHOEA (diarrhea) outcome was unknown and INFLAMMATION (inflammation), MUSCULOSKELETAL STIFFNESS (leg stiffening at night), PAIN IN EXTREMITY (arms hands legs in pain), DYSSTASIA (difficult to get up), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (Pain in knees and wrist/extreme joint pain) and MYALGIA (Extremely muscle pain in legs and knees / muscle pains/excruciating muscle pain) had not resolved. Based on current available information and the temporal relationship between product use and the start date of the events a causal relationship cannot be excluded. No concomitant medications were provided by reporter. No treatment medications were provided by reporter. This case was linked to MOD-2021-175593. Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Significant follow up added: Serious event of Paralysis and other non-serious events added. Outcome of events updated as per narrative. On 07-Jul-2021: Follow-up information received on 07-JUL-2021 contains No Significant Information.; Sender's Comments: Based on current available information and the temporal relationship between product use and the start date of the events a causal relationship cannot be excluded.
Severe chills, shaking, fever, body aches. Fever high enough for hallucination, hallucinations partially alleviated by application of cold rag to forehead. Shaking was severe enough to impact mobility (hard to walk) All adverse events began approximately 12 hours after second series injection.
Joint pain; fever; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain), PYREXIA (fever) and MYALGIA (Muscle ache) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SEMAGLUTIDE (OZEMPIC) and INSULIN DEGLUDEC (TRESIBA) for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint pain), PYREXIA (fever) and MYALGIA (Muscle ache). At the time of the report, ARTHRALGIA (Joint pain), PYREXIA (fever) and MYALGIA (Muscle ache) outcome was unknown.            Concomitant medication not provided. Treatment medication not provided
By night had fever, in bed on Sunday, with fever, sore arm, hives from elbow to shoulder and al the way to chest.  Doctor visit on Monday given antibiotics for possible Cellulitis infection.  Treated with Keflex, taking Benadryl since Sunday, and aspirin for headache.  Today arm sore and red blotches, antibiotics don't seem to work yet.
hearing Loss; zoster-related conditions; zoster-related conditions; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. Information about the patient's concurrent condition, concomitant medication or medical history was not provided. On or about in 2012, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) by a pharmacist for the long-term prevention of shingles and zoster-related conditions. At the time of patient's vaccination, patient relied on the warning label affixed to zoster vaccine live(ZOSTAVAX), and the information relayed through patient's healthcare provider(s) that zoster vaccine live(ZOSTAVAX)was an effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effect, which induced patient to be vaccinated. On an unspecified date (reported as subsequent to the inoculation), the patient was treated by healthcare providers for hearing loss, and other zoster-related conditions. As a direct and proximate result of patient's use of the zoster vaccine live(ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the events was not recovered. The reporter considered the events to be related to Zoster Vaccine Live(ZOSTAVAX).  Upon internal review, hearing loss was determined to be medically significant.
rash; Hives; This is a spontaneous report from a contactable consumer. This consumer reported for a 62-year-old female patient received first dose of BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not reported) via unspecified route of administration in left arm on 4Feb2021 (age at vaccination 62-year-old) as single dose for COVID-19 immunisation. The patient medical history, concomitant medications and past drug history were not reported. On 14Feb2021, patient experienced rash and hives. Reporter states he was calling for his wife, states she received the first shot on 04Feb2021 and after the first one about a week and a half later, 10 days later, she had a rash and hives, states it went away in 2-3 days and they did not think anything of it. Patient started treating hives with calamine lotion late night 28Feb2021. Reporter confirms wife received the Pfizer Covid vaccine, does not have patient card with him to provide NDC, Lot or Expiration Dates for either dose. States she received both doses in her left arm. The outcome of the events were recovered on an unknown date in Feb2021.  No follow-up attempts are Possible. Information about lot/batch number cannot be obtained.  No further information is expected.
Chronic and severe all over body ache; Muscle aches; Swollen and painful joints; Swollen and painful joints; Headache; Fatigue; Back spasms; swollen/painful lymph nodes under both armpits; swollen/painful lymph nodes under both armpits; This is a spontaneous report from a contactable consumer (patient). A 53-Year old Female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EW0150, on 16Mar2011 11:00 at single dose in right arm (at the age of 53-year-old) for COVID-19 immunization. Medical history included Depression, Attention deficit hyperactivity disorder (ADHD), Hashimoto's disease, Fibromyalgia, Rheumatoid disease, and known allergies Latex. Concomitant medication included unspecified medication. The patient did not receive other vaccine in four weeks. The patient received Other medications in two weeks. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. On 17Mar2021 12:00, the patient experienced Chronic and severe all over body ache, muscle aches, swollen and painful joints, headache, fatigue, back spasms and swollen/painful lymph nodes under both armpits. She had appointment with PCP for referral to rheumatologist 09May2021. All events resulted in Doctor or other healthcare professional office/clinic visit. It was unknown if treatment was received for events. Lab data included HLA-B27 gene positive. The outcome of all events was not resolved.  Follow-up actions are needed. Further information has been requested.
Pain in Arm; Pain up her neck and up to her head that worse at night and very painful to lay in bed; Difficulty getting dressed; Lots of pain in her arms all the time/experienced this same pain in her legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in Arm), NECK PAIN (Pain up her neck and up to her head that worse at night and very painful to lay in bed), MOBILITY DECREASED (Difficulty getting dressed) and PAIN IN EXTREMITY (Lots of pain in her arms all the time/experienced this same pain in her legs) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027A21A) for COVID-19 vaccination.     The patient's past medical history included Polymyalgia rheumatica. Previously administered products included for an unreported indication: PREDNISONE and STEROIDS (she was taking 60mg since from 6 years she stopped taking steroid before it she changed her dose to 1 mg.).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in Arm), NECK PAIN (Pain up her neck and up to her head that worse at night and very painful to lay in bed), MOBILITY DECREASED (Difficulty getting dressed) and PAIN IN EXTREMITY (Lots of pain in her arms all the time/experienced this same pain in her legs). The patient was treated with METHOTREXATE on 14-Jul-2021 at an unspecified dose and frequency; FOLIC ACID at an unspecified dose and frequency and IRON at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in Arm), NECK PAIN (Pain up her neck and up to her head that worse at night and very painful to lay in bed), MOBILITY DECREASED (Difficulty getting dressed) and PAIN IN EXTREMITY (Lots of pain in her arms all the time/experienced this same pain in her legs) outcome was unknown.            The concomitant medication was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Significant follow up received and added new events.
Local reaction, rt. arm, grade 3 at 130cm x 75cm with pain, edema, redness.
This case was reported by  a nurse to a sales representative and described the occurrence of limb swelling in a subject of unspecified age and gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date in June 2006, the subject received a dose of Infanrix (lot number and dose number were not reported) at an unspecified site of administration. On an unspecified date on or before 27 June 2006 after vaccination with Infanrix, the subject experienced limb swelling and redness. The outcome of the events was unknown.
Patient contacted pharmacy on 08/15/2021, stating she had swelling and redness in the injection site and asked if this was normal.  I instructed pt to get the vaccination site looked at by MD, classic description of cellulitus.  Patient said she would go to urgent care to have it looked at and will report back to us with any findings.  Initiating  Vaers reporting, will update as needed once additional information is obtained.
Information has been received from a healthcare worker concerning an approximately 13 year old male who on an unspecified date was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed a fever, and large swelling at the injection site, with redness and heat at the injection site. No further information was provided. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
Fever (100.7 F), Chills,  Sore arm, Fatigue
Client's mother called to report 102F fever and nausea, starting approximately 36-48 hours, post vax.
This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Soreness in injection arm), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itchiness at injection site) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. Concomitant products included PANTOPRAZOLE for an unknown indication. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE PAIN (Soreness in injection arm). On 17-Apr-2021, the patient experienced VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itchiness at injection site). On 11-Apr-2021, VACCINATION SITE PAIN (Soreness in injection arm) had resolved. At the time of the report, VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itchiness at injection site) had not resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication not provided.  Treatment medication not provided.
patient contracted COVID, positive PCR on 06Jan2021; patient contracted COVID, positive PCR on 06Jan2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the parent.  A 12 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Oct2021 16:00 (Lot number: FF2590) at the age of 12 years as dose 2, single and administered in arm left, administration date 30Sep2021 16:00 (Lot number: 30155BA) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 06Jan2022, outcome "recovering" and all described as "patient contracted COVID, positive PCR on 06Jan2021". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.   The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination,the patient  was not diagnosed with COVID-19.Since the vaccination, the patient has been tested for COVID-19.  No follow-up attempts are needed; information about lot/batch number cannot be obtained